Operating revenue rose 4% to $259.9m and net profit after tax increased 1% to $5.6m year-over-year. Pharmacy profit grew despite flat revenue, while medical revenue and profit saw double-digit gains. Interim dividend of 2.5cps declared.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.